HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Poloznikov, Andrey A, Nersisyan, Stepan A, Hushpulian, Dmitry M, Kazakov, Eliot H, Tonevitsky, Alexander G, Kazakov, Sergey V, Vechorko, Valery I, Nikulin, Sergey V, Makarova, Julia A, Gazaryan, Irina G
Published in Frontiers in pharmacology (29.01.2021)
Published in Frontiers in pharmacology (29.01.2021)
Get full text
Journal Article
HLA-A01:01 allele diminishing in COVID-19 patients population associated with non-structural epitope abundance in CD8+ T-cell repertoire
Shkurnikov, Maxim, Nersisyan, Stepan, Averinskaya, Darya, Chekova, Milena, Polyakov, Fedor, Titov, Aleksei, Doroshenko, Dmitriy, Vechorko, Valery, Tonevitsky, Alexander
Published in PeerJ (San Francisco, CA) (18.01.2023)
Published in PeerJ (San Francisco, CA) (18.01.2023)
Get full text
Journal Article
Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19
Temirbulatov, I. I., Kryukov, A. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, Sh. P., Kachanova, A. A., Sozaeva, Zh. A., Zhiryakova, A. S., Shevchuk, Yu. V., Vechorko, V. I., Averkov, O. V., Sychev, D. A.
Published in Medicinskij sovet (18.01.2023)
Published in Medicinskij sovet (18.01.2023)
Get full text
Journal Article